The Coagulation Test Products market includes testing for PT, aPTT, and other factors involved in the clotting cascade. Much of the testing occurs in the laboratory and Near Patient Testing (NPT) settings, but individuals taking anti-clotting agents such as warfarin need to monitor clotting levels and therefore compose the Patient Self-Testing (PST) segment.
Coagulation testing is conducted in laboratory, ambulatory, and PST environments. The laboratory-based testing is typically composed of routine testing for PT and aPTT, but also includes other tests for bleeding disorders. NPT and PST monitor routine PT and aPTT, but do not involve other clotting factors.
The leading worldwide manufacturers of coagulation systems include:
Market Assessment/Monitoring Reports:
Relevant Conferences: